143 Pilot study of concurrent weekly irinotecan (CPT-11) and daily carboplatin (CBDCA) with thoracic radiation therapy (TRT) in locally advanced non-small cell lung cancer (NSCLC)Irinotecan has appeared to have significant activity against previously treated and untreated small-cell lung cancer (...
P- 582 Dose- finding study of weekly irinotecan(CPT- 11 ) and carboplatin (CBDCA) with concurrent thoracic radiotherapy (TRT) in locally advanced non- small cell lung cancer (NSCLC) [ J ]. Lung Cancer, 2003, 41 (s2) : S238.
Phase II study of irinotecan (CPT-11) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2000;19:534a.Mukohara I, Takeda K, Miyazaki M, et al. Phase II study of irinotecan (CPT-11) and carboplatin (CBDCA) in advanced non- small cell ...
Phase II study of irinotecan (CPT-11) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2000;19:534a.Mukohara I, Takeda K, Miyazaki M, et al. Phase II study of irinotecan (CPT-11) and carboplatin (CBDCA) in advanced non- small cell ...